The Chicago Tribune is reporting on a Town Hall meeting Baxter Chairman and Chief Executive Bob Parkinson had on the 23rd:
His [Parkinson] 9-minute "town hall meeting'' with employees was almost solely focused on heparin, a product sold in vials that generates about $30 million of the company's more than $11 billion in annual sales.
So heparin accounts for less than a third of one percent of sales but it is an important medication:
Parkinson said Baxter is providing more than 6 million injections or infusions a day to patients "far and away more than any other company in the world.'' He added, "every product we sell...is the difference between life and death.''
Compare his acknowledgment of their duty with the finger pointing and blame shifting of the Chinese delegation on Monday.
Parkinson said Baxter's inspection process, which has since been intensified, would not have been able to detect the heparin-like substance he said appears now to have been put into the supply chain by an "unscrupulous character" motivated by profit.
The FDA, Baxter and other companies are now using new MRI-like detection technology and other high-tech methods to examine heparin products at the border.
All products coming from China should be subject to intensified inspections. (note that there is video posted on the Baxter website but I could not get the video to work)